Complete Study of Coronavac Vaccine Will Be Revealed on December 23
SP postpones disclosure of Covid vaccine efficacy to send data to China and studies reaction of STF against Bolsonaro government
Confident in the high effectiveness of Coronavac, the government of São Paulo changed its tactic to pressure Anvisa (National Health Surveillance Agency) to approve the vaccine against Covid-19 later this year.
If that fails, however, judicial measures are already being studied to take the "vaccine war" between President Jair Bolsonaro (without a party) and Governor João Doria (PSDB-SP) to the Supreme Court.
The state was supposed to disclose the preliminary effectiveness of phase 3 on Tuesday (15). Still, the state will wait until the 23rd and present the complete trial to request the Chinese vaccine's approval by Anvisa.
In addition, in agreement with the Chinese manufacturer Sinovac, the vaccine will seek approval with NMPA (National Administration of Medical Products), Anvisa of the Asian country.
It is expected that China will register Coronavac in about three days.
Translated by Kiratiana Freelon